Abstract
Research participants are required to give their consent to participate in clinical trials and nonexempt government-funded studies. The goal is to facilitate participant understanding of the intent of the research, its voluntary nature, and the potential benefits and harms. Ideally, participants make an informed choice whether to participate; one that is based on having sufficient relevant knowledge and that is consistent with their values and preferences. Achieving this objective can be challenging, and as such, many scholars have declared the consent process flawed or “broken.” Moreover, clinical trials are complex studies, and compelling evidence suggests that current consent processes are inadequate in achieving informed choice. E-consent offers a dynamic, engaging consent delivery mode that can effectively support making informed decisions about whether to participate in a trial.
Reference34 articles.
1. 1. Department of Homeland Security, Department of Agriculture, Department of Energy, National Aeronautics and Space Administration, Department of Commerce, Social Security Administration, Agency for International Development, et al. Federal policy for the protection of human subjects. Fed Reg 2017 Jan 19;82(12):7149-274. https://www.govinfo.gov/content/pkg/FR-2017-01-19/pdf/2017-01058.pdf
2. 2. Menikoff J, Kaneshiro J, Pritchard I. The common rule, updated. NEJM 2017;376(7):613-5. https://doi.org/10.1056/NEJMp1700736
3. 3. Stryker JE, Wray RJ, Emmons KM, Winer E, Demetri G. Understanding the decisions of cancer clinical trial participants to enter research studies: Factors associated with informed consent, patient satisfaction, and decisional regret. Patient Educ Counseling 2006;63(1-2):104-9. https://doi.org/10.1016/j.pec.2005.09.006
4. 4. Lee R, Lampert S, Wilder L, Sowell AL. Subjects agree to participate in environmental health studies without fully comprehending the associated risk. Intern J Environ Res Public Health 2011;8:830-41. https://doi.org/10.3390/ijerph8030830
5. 5. Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent in cancer clinical trials: A cross-sectional survey. Lancet 2001;358(9295), 1772-7. https://doi.org/10.1016/S0140-6736(01)06805-2